Clinicians began exploring this approach for a few reasons: Not everyone needs aggressive appetite suppression to improve metabolic health Some people are more sensitive to GLP-1 medications Side effects often increase with higher doses Cost and long-term sustainability matter Women, in particular, started asking different questions
TB001, a dual agonist of GLP-1R and GCGR, synthesized by School of Pharmaceutical Sciences of Sun Yat-sen University, effectively regulates glucose levels and body weight
Patient experiences reflect personal outcomes and are not a guarantee of similar results
All our raw materials and finished products go through stringent testing to meet our high-quality standards
References GLP-1 Agonists: Mechanisms to Applications Wilding JPH, Batterham RL, Calanna S, et al
Choose the option that reflects your average week, not your best week